Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP vs MPT for Newly Diagnosed Elderly Multiple Myeloma
NCT01274403Phase 2Completed
- Sponsor
- Gruppo Italiano Studio Linfomi
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in multiple myeloma (MM), sponsored by Gruppo Italiano Studio Linfomi. Status: completed.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01274403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01274403.